Assurance Report on the Correction of Significant Prior Period Errors
Tianjian Audit [2026] No. 8-547
To all shareholders of Guizhou Bailing Enterprise Group Pharmaceutical Co., Ltd.:
We have audited the accompanying "Explanation on the Correction of Significant Prior Period Errors" prepared by the management of Guizhou Bailing Enterprise Group Pharmaceutical Co., Ltd. (hereinafter referred to as Guizhou Bailing Company).
I. Limitation on Users and Purpose of the Report
This assurance report is only for use by Guizhou Bailing Company when disclosing the correction of significant prior period errors and shall not be used for any other purpose.
II. Management's Responsibility
The responsibility of Guizhou Bailing Company's management is to provide true, lawful, and complete relevant information and to prepare the "Explanation on the Correction of Significant Prior Period Errors" in accordance with the "Accounting Standards No. 28 – Changes in Accounting Policies, Accounting Estimates and Errors" and the "Rules for Information Disclosure and Reporting of Publicly Issued Securities No. 19 – Correction and Related Disclosure of Financial Information (2025 Revision)" (CSRC Announcement [2025] No. 5), and to ensure that its content is true, accurate, and complete, without any false records, misleading statements, or major omissions.
III. Responsibility of the Certified Public Accountant
Our responsibility is to independently express an assurance conclusion based on the performance of the assurance work on the aforementioned explanation prepared by the management of Guizhou Bailing Company.